Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges
It is estimated that over 200 million adults worldwide have osteoporosis, a disease that has increasing socioeconomic impact reflected by unsustainable costs associated with disability, fracture management, hospital stays, and treatment. Existing therapeutic treatments for osteoporosis are associate...
Saved in:
Main Authors: | Claire MacNabb, D. Patton, J. S. Hayes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.1155/2016/6217286 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of anti-sclerostin antibody on orthodontic tooth movement in ovariectomized rats
by: Hyunna Ahn, et al.
Published: (2024-11-01) -
Correction to: Effect of anti-sclerostin antibody on orthodontic tooth movement in ovariectomized rats
by: Hyunna Ahn, et al.
Published: (2025-01-01) -
Role of sclerostin in mastocytosis bone disease
by: Aneta Szudy-Szczyrek, et al.
Published: (2025-01-01) -
RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis
by: Alicia K. Morgans, et al.
Published: (2011-01-01) -
Therapy of Osteoporosis in Men with Teriparatide
by: Natalie E. Cusano, et al.
Published: (2011-01-01)